|
|
Poll Results
Have you considered switching to Lantus (insulin glargine)?
Injection users
I already switched to Lantus
26%
170
Yes, I'm considering switching
7%
45
No, I'm not going to switch
9%
63
Pump users
I already switched from the pump to injections with Lantus
1%
4
Yes, I'm considering switching from the pump to Lantus
1%
6
No, I'm sticking with the pump
35%
224
Other
I don't use insulin
1%
4
Lantus is not yet available in my country
3%
22
What's Lantus?
14%
93
Have you considered switching to Lantus (insulin glargine)?
Poll dates: October 6 - 13, 2002
Total Votes: 631Lantus® (insulin glargine) is a new, very long acting insulin. It has a remarkably flat action profile that lasts 24 hours, making it an excellent basal insulin. Of injection users who know about Lantus, over 60% have already switched their basal insulin to Lantus, and another 16% are considering it. Interest among pump users is considerably less, with 96% of pump users planning to stick with insulin pump therapy. Only 14% of people who responded were unfamiliar with Lantus. The table below summarizes the responses based on insulin regimen.
278 injection, 234 pump, 512 total
Insulin
TherapySwitched
AlreadyConsidering
SwitchingNot
Considering
SwitchingInjection 61% 16% 23% Pump 2% 3% 96% Overall 34% 10% 56% Compared to the last time we ran this poll in August 2001, about twice as many injection users (61% vs. 34%) report having switched to using Lantus.
Insulin analogs like Lantus, Humalog, and NovoLog offer new choices for people with diabetes who use insulin. Plus, there are even more new insulins on the horizon. If you're unfamiliar with these new insulins, ask your diabetes team about them.
|
|
|||
Last Updated: Wednesday March 16, 2005 15:37:13
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.